AHCC RESEARCH  Manufacturer Contact Us |
|
For Release: Immediate 10th International AHCC® & GCP™ Symposium Proves Valuable Sharing of Worldwide Research U.S. Association Presented Prestigious NutrAward
to Host Country SAPPORO, Japan, September 3, 2002 - Over 350 medical doctor from around the world shared their latest discoveries and research studies at the 10th International Symposium of the AHCC® (Active Hexose Correlated Compound) and GCP™ (Genistein Combined Polysaccharide) Research Associations meeting. The Symposium was co-sponsored by The Foundation for Basic Research of Oncology (the association authorized by the Japanese Ministry of Health and Welfare as an official foundation to execute and support basic research projects on cancer) and Amino Up Chemical Co., Ltd., headquartered in Sapporo, Japan. Attending nations included China, Finland, Japan, Korea, New Zealand, Thailand, United Kingdom and the United States. The AHCC Research Association, www.AHCCresearch.com, and the GCP Research Association, www.GCPresearch.com, were established in the U.S. to promote clinical research of nutritional supplements, as well as physician and patient education. Discussions of new AHCC and GCP clinical research studies and developments were the focus of the Symposium. The agenda consisted of four basic studies and ten clinical studies on AHCC, two basic studies and three clinical studies on GCP and one basic study and one clinical study on the combined usage of AHCC and GCP. The keynote lecturer, Dr. Noriaki Tanaka (Okayama Univ., Japan) spoke on The Current Tumor Therapy. "This year, one of the most significant AHCC studies presented was titled ‘Improved Prognosis of Postoperative Hepatocellular Carcinoma Patients When Treated with Functional Foods: A Prospective Cohort Study’ conducted by Dr. Yasuo Kamiyama, Professor of Kansai Medical University in Osaka, Japan," stated Fred Pescatore, M.D., M.P.H., of the Centers For Integrative and Complementary Medicine, and medical director for the U.S. AHCC Research Association. " This study measured the effects of AHCC on post-operative liver cancer patients over a nine-year period based on ten different parameters and really reinforces the efficacy of AHCC. A synopsis of the study was also published in the Journal of Hepatology -- The Official Journal of the European Association for the Study of Liver." Dr. Fred Pescatore, M.D., concluded the two-day Symposium with a presentation on new case studies and follow-up reports on AHCC. Other presenters from the U.S. included: Dan Kenner, N.D., who presented various studies of AHCC completed in the U.S.; Thomas Walshe, M.D., Harvard Medical School and Faulkner Hospital, Boston, Massachusetts, who presented a pilot study on the effects of AHCC with Hepatitis C patients; and Dennis O’Hara, who presented a combined abstract on a Testimonial Trial using GCP. During an exclusive reception at the Symposium, members of the U.S. AHCC Association, presented a copy of the esteemed NutrAward they received at the Nutracon Conference, to the founding company and Symposium sponsor, Amino Up Chemical Co., Ltd. In March, Quality of Life Labs received the NutrAward, Best New Product of 2002, for their ingredient AHCC, at the Nutracon Conference. Nutracon is the leading educational and networking event for top-level executives in the cosmeceutical, dietary supplement, nutraceutical and functional/medical foods industries in the United States. Executives at the Nutracon Conference awarded AHCC this honor on behalf of its scientific merit, efficacy, safety, innovation, market potential and credibility to advance industry.   If you are interested in receiving further details, meeting notes or abstracts from the 10th International Symposium of AHCC® and GCP™ Research Associations, please contact Tiia Sumera at tiias@imgbranding.com. Details will also be added to the Web sites, www.AHCCresearch.com and www.GCPresearch.com, as soon as they are available. AHCC® (Active Hexose Correlated Compound) AHCC is derived from a highly specialized manufacturing process developed in the mid-1980s that relies on the hybridization of several species of mushrooms cultivated in Japan. According to industry analysts in Japan, over 700 hospitals and medical clinics recommend AHCC to patients in that country as part of an immune enhancement maintenance regimen, creating a $150 million (USD) industry. AHCC has been the subject of numerous clinical studies conducted at prestigious Japanese institutions such as Hokkaido University, Kyorin University and Teikyo University. Currently 40,000 individuals worldwide use the nutritional supplement monthly. GCP™ (Genistein Combined Polysaccharide) GCP is an extract produced through the fermentation of soybean isoflavones and medicinal mushrooms. Numerous research studies have shown that GCP inhibits angiogenesis and cell proliferation. GCP is well tolerated by the body with no known serious side effects and is highly bioavailable for use by the body. |